Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages

IntroductionLipoprotein(a) (Lp(a)) is an LDL-like particle with an additional apolipoprotein (apo)(a) covalently attached. Elevated levels of circulating Lp(a) are a risk factor for atherosclerosis. A proinflammatory role for Lp(a) has been proposed, but its molecular details are incompletely define...

Full description

Bibliographic Details
Main Authors: Martina B. Lorey, Amer Youssef, Lauri Äikäs, Matthew Borrelli, Martin Hermansson, Julia M. Assini, Aapeli Kemppainen, Hanna Ruhanen, Maija Ruuth, Sampsa Matikainen, Petri T. Kovanen, Reijo Käkelä, Michael B. Boffa, Marlys L. Koschinsky, Katariina Öörni
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1130162/full
_version_ 1827942130330370048
author Martina B. Lorey
Martina B. Lorey
Amer Youssef
Lauri Äikäs
Matthew Borrelli
Martin Hermansson
Julia M. Assini
Julia M. Assini
Aapeli Kemppainen
Hanna Ruhanen
Hanna Ruhanen
Maija Ruuth
Sampsa Matikainen
Petri T. Kovanen
Reijo Käkelä
Reijo Käkelä
Michael B. Boffa
Michael B. Boffa
Marlys L. Koschinsky
Marlys L. Koschinsky
Katariina Öörni
Katariina Öörni
author_facet Martina B. Lorey
Martina B. Lorey
Amer Youssef
Lauri Äikäs
Matthew Borrelli
Martin Hermansson
Julia M. Assini
Julia M. Assini
Aapeli Kemppainen
Hanna Ruhanen
Hanna Ruhanen
Maija Ruuth
Sampsa Matikainen
Petri T. Kovanen
Reijo Käkelä
Reijo Käkelä
Michael B. Boffa
Michael B. Boffa
Marlys L. Koschinsky
Marlys L. Koschinsky
Katariina Öörni
Katariina Öörni
author_sort Martina B. Lorey
collection DOAJ
description IntroductionLipoprotein(a) (Lp(a)) is an LDL-like particle with an additional apolipoprotein (apo)(a) covalently attached. Elevated levels of circulating Lp(a) are a risk factor for atherosclerosis. A proinflammatory role for Lp(a) has been proposed, but its molecular details are incompletely defined.Methods and resultsTo explore the effect of Lp(a) on human macrophages we performed RNA sequencing on THP-1 macrophages treated with Lp(a) or recombinant apo(a), which showed that especially Lp(a) induces potent inflammatory responses. Thus, we stimulated THP-1 macrophages with serum containing various Lp(a) levels to investigate their correlations with cytokines highlighted by the RNAseq, showing significant correlations with caspase-1 activity and secretion of IL-1β and IL-18. We further isolated both Lp(a) and LDL particles from three donors and then compared their atheroinflammatory potentials together with recombinant apo(a) in primary and THP-1 derived macrophages. Compared with LDL, Lp(a) induced a robust and dose-dependent caspase-1 activation and release of IL-1β and IL-18 in both macrophage types. Recombinant apo(a) strongly induced caspase-1 activation and IL-1β release in THP-1 macrophages but yielded weak responses in primary macrophages. Structural analysis of these particles revealed that the Lp(a) proteome was enriched in proteins associated with complement activation and coagulation, and its lipidome was relatively deficient in polyunsaturated fatty acids and had a high n-6/n-3 ratio promoting inflammation.DiscussionOur data show that Lp(a) particles induce the expression of inflammatory genes, and Lp(a) and to a lesser extent apo(a) induce caspase-1 activation and IL-1 signaling. Major differences in the molecular profiles between Lp(a) and LDL contribute to Lp(a) being more atheroinflammatory.
first_indexed 2024-03-13T09:54:05Z
format Article
id doaj.art-e718ebe0203e44b68e68438c5b4d9562
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-03-13T09:54:05Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-e718ebe0203e44b68e68438c5b4d95622023-05-24T04:39:35ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2023-05-011010.3389/fcvm.2023.11301621130162Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophagesMartina B. Lorey0Martina B. Lorey1Amer Youssef2Lauri Äikäs3Matthew Borrelli4Martin Hermansson5Julia M. Assini6Julia M. Assini7Aapeli Kemppainen8Hanna Ruhanen9Hanna Ruhanen10Maija Ruuth11Sampsa Matikainen12Petri T. Kovanen13Reijo Käkelä14Reijo Käkelä15Michael B. Boffa16Michael B. Boffa17Marlys L. Koschinsky18Marlys L. Koschinsky19Katariina Öörni20Katariina Öörni21Atherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, FinlandMolecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, FinlandRobarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, CanadaAtherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, FinlandDepartment of Physiology & Pharmacology, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, CanadaAtherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, FinlandRobarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, CanadaDepartment of Biochemistry, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, CanadaAtherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, FinlandMolecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, FinlandHelsinki University Lipidomics Unit (HiLIPID), Helsinki Institute of Life Science (HiLIFE) and Biocenter Finland, Helsinki, FinlandAtherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, FinlandHelsinki Rheumatic Disease and Inflammation Research Group, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandAtherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, FinlandMolecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, FinlandHelsinki University Lipidomics Unit (HiLIPID), Helsinki Institute of Life Science (HiLIFE) and Biocenter Finland, Helsinki, FinlandRobarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, CanadaDepartment of Biochemistry, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, CanadaRobarts Research Institute, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, CanadaDepartment of Physiology & Pharmacology, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, ON, CanadaAtherosclerosis Research Laboratory, Wihuri Research Institute, Helsinki, FinlandMolecular and Integrative Biosciences, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, FinlandIntroductionLipoprotein(a) (Lp(a)) is an LDL-like particle with an additional apolipoprotein (apo)(a) covalently attached. Elevated levels of circulating Lp(a) are a risk factor for atherosclerosis. A proinflammatory role for Lp(a) has been proposed, but its molecular details are incompletely defined.Methods and resultsTo explore the effect of Lp(a) on human macrophages we performed RNA sequencing on THP-1 macrophages treated with Lp(a) or recombinant apo(a), which showed that especially Lp(a) induces potent inflammatory responses. Thus, we stimulated THP-1 macrophages with serum containing various Lp(a) levels to investigate their correlations with cytokines highlighted by the RNAseq, showing significant correlations with caspase-1 activity and secretion of IL-1β and IL-18. We further isolated both Lp(a) and LDL particles from three donors and then compared their atheroinflammatory potentials together with recombinant apo(a) in primary and THP-1 derived macrophages. Compared with LDL, Lp(a) induced a robust and dose-dependent caspase-1 activation and release of IL-1β and IL-18 in both macrophage types. Recombinant apo(a) strongly induced caspase-1 activation and IL-1β release in THP-1 macrophages but yielded weak responses in primary macrophages. Structural analysis of these particles revealed that the Lp(a) proteome was enriched in proteins associated with complement activation and coagulation, and its lipidome was relatively deficient in polyunsaturated fatty acids and had a high n-6/n-3 ratio promoting inflammation.DiscussionOur data show that Lp(a) particles induce the expression of inflammatory genes, and Lp(a) and to a lesser extent apo(a) induce caspase-1 activation and IL-1 signaling. Major differences in the molecular profiles between Lp(a) and LDL contribute to Lp(a) being more atheroinflammatory.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1130162/fullinflammationlipoprotein(a)apolipoproteinsatherosclerotic cardiovascular diseaseatherosclerosiscaspase-1
spellingShingle Martina B. Lorey
Martina B. Lorey
Amer Youssef
Lauri Äikäs
Matthew Borrelli
Martin Hermansson
Julia M. Assini
Julia M. Assini
Aapeli Kemppainen
Hanna Ruhanen
Hanna Ruhanen
Maija Ruuth
Sampsa Matikainen
Petri T. Kovanen
Reijo Käkelä
Reijo Käkelä
Michael B. Boffa
Michael B. Boffa
Marlys L. Koschinsky
Marlys L. Koschinsky
Katariina Öörni
Katariina Öörni
Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages
Frontiers in Cardiovascular Medicine
inflammation
lipoprotein(a)
apolipoproteins
atherosclerotic cardiovascular disease
atherosclerosis
caspase-1
title Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages
title_full Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages
title_fullStr Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages
title_full_unstemmed Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages
title_short Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages
title_sort lipoprotein a induces caspase 1 activation and il 1 signaling in human macrophages
topic inflammation
lipoprotein(a)
apolipoproteins
atherosclerotic cardiovascular disease
atherosclerosis
caspase-1
url https://www.frontiersin.org/articles/10.3389/fcvm.2023.1130162/full
work_keys_str_mv AT martinablorey lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT martinablorey lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT ameryoussef lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT lauriaikas lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT matthewborrelli lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT martinhermansson lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT juliamassini lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT juliamassini lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT aapelikemppainen lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT hannaruhanen lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT hannaruhanen lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT maijaruuth lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT sampsamatikainen lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT petritkovanen lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT reijokakela lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT reijokakela lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT michaelbboffa lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT michaelbboffa lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT marlyslkoschinsky lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT marlyslkoschinsky lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT katariinaoorni lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages
AT katariinaoorni lipoproteinainducescaspase1activationandil1signalinginhumanmacrophages